Glenmark Pharmaceuticals

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue3,1473,1733,0192,7773,375
Expenses2,6802,7782,7702,4922,909
EBITDA466.98395.84249.35284.85465.86
EBIT343.79276.91117.83138.09310.15
Profit Before Tax384.96343.04269.69408.01480.21
Net Profit257.66221.90155.58192.53260.44
Financial Ratios
Operating Profit Margin14.84%12.47%8.26%10.26%13.80%
Net Profit Margin8.19%6.99%5.15%6.93%7.72%
Earning Per Share (Diluted)9.1312.287.396.829.23
Dividends Per ShareNANA2.50NANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI